DEDICATED TO EXCELLENCE IN CUSTOM SYNTHESIS

Alchem has twenty four years of government contract experience with NIH, DOD, and BARDA. Alchem’s government contract experience has led to excellent CPARS ratings. Alchem is currently NCI’s main contractor for non-GMP and GMP API synthesis projects supporting NCI clinical trials.

• HDTRA12410002 “Screening and Development of Small Molecule Venezuelan Equine Encephalitis Virus (VEEV) Non-Structural Protein 2 Cysteine Protease Inhibitors” (10/30/23-10/29/27)

• 75N91023D00006 “Analysis and Synthesis of GMP and non-GMP Bulk Drugs and Pharmaceutical Formulations” (4/11/23-4/10/28)

• HHSN261201700007I “Synthesis of Non-GMP Small Molecules” 5-year IDIQ contract with NCI (9/18/17-9/17/22 extended to 6/4/27)

• 75N95019D00028 “CRO Support for NCATS Medicinal Chemistry for Lead Optimization” 5-year IDIQ contract with NCATS-NIDA (9/26/19-9/25/24)

• 75N98019D00057 “Drug Formulation and Manufacturing Contract” 5-year IDIQ contract with NIH (9/27/19-9/26/24)

• 19-05 (TRE) “Prophylactic and Therapeutic cMCM Libraries, Mid to Late Pipeline Development” with JPEO-CBRND MCS under OTA W15QKN1691002 to ATI

• 75N93021D00002 “Preclinical Services for HIV Therapeutics” 7-year IDIQ contract with NIAID (10/15/20-10/14/27)

  • Task Area A: In Vitro Testing and Screening Resource for Therapeutics

  • Task Area B: Synthesis of Therapeutic Agents for Treatment of Infectious Diseases

  • Task Area E: Formulation Development and Manufacture of Clinical Dosage Forms